106 related articles for article (PubMed ID: 15497745)
1. Synthesis of potential metabolites of (S)-(-)-bromofosfamide.
Misiura K
Pharmazie; 2004 Sep; 59(9):668-72. PubMed ID: 15497745
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioavailability of stereoisomeric analogues of ifosfamide.
Sloderbach A; Hładoń B; Laskowska H
Acta Physiol Hung; 1996; 84(4):459-60. PubMed ID: 9328631
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the urinary excretion of ifosfamide and its N-dechloroethylated metabolites in children using 31P-NMR spectroscopy.
Misiura K; Zubowska M; Zielińska E
Arzneimittelforschung; 2003; 53(5):372-7. PubMed ID: 12854365
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-stereoselective differentiation of some isomeric analogues of ifosfamide.
Sloderbach A; Hładoń B; Sochacki M; Kinas R; Kuśnierczyk H; Laskowska H
Pol J Pharmacol; 1997; 49(6):463-9. PubMed ID: 9566050
[TBL] [Abstract][Full Text] [Related]
5. (S)-(-)-Bromofosfamide (CBM-11): synthesis and antitumor activity and toxicity in mice.
Misiura K; Kinas RW; Kuśnierczyk H; Radzikowski C; Stec WJ
Anticancer Drugs; 2001 Jun; 12(5):453-8. PubMed ID: 11395573
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of (-)-(S)-bromofosfamide after intravenous and oral administration in mice.
Kobylińska K; Kobylińska M; Sobik B
Arzneimittelforschung; 2001; 51(7):596-9. PubMed ID: 11505792
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ifosfamide and some metabolites in children.
Kaijser GP; De Kraker J; Bult A; Underberg WJ; Beijnen JH
Anticancer Res; 1998; 18(3B):1941-9. PubMed ID: 9677448
[TBL] [Abstract][Full Text] [Related]
8. Glufosfamide as a new oxazaphosphorine anticancer agent.
Mazur L; Opydo-Chanek M; Stojak M
Anticancer Drugs; 2011 Jul; 22(6):488-93. PubMed ID: 21427562
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and toxicity of oral (-)-(S)-bromofosfamide in lung cancer patients.
Kobylińska K; Koralewski P; Sobik B; Gasiorek M; Kobylińska M
Arzneimittelforschung; 2001; 51(7):600-3. PubMed ID: 11505793
[TBL] [Abstract][Full Text] [Related]
10. New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activity.
Storme T; Deroussent A; Mercier L; Prost E; Re M; Munier F; Martens T; Bourget P; Vassal G; Royer J; Paci A
J Pharmacol Exp Ther; 2009 Feb; 328(2):598-609. PubMed ID: 19017849
[TBL] [Abstract][Full Text] [Related]
11. Influence of dose and infusion duration on pharmacokinetics of ifosfamide and metabolites.
Kerbusch T; Mathôt RA; Keizer HJ; Kaijser GP; Schellens JH; Beijnen JH
Drug Metab Dispos; 2001 Jul; 29(7):967-75. PubMed ID: 11408362
[TBL] [Abstract][Full Text] [Related]
12. A tubule cell model for ifosfamide nephrotoxicity.
Aleksa K; Halachmi N; Ito S; Koren G
Can J Physiol Pharmacol; 2005 Jun; 83(6):499-508. PubMed ID: 16049550
[TBL] [Abstract][Full Text] [Related]
13. Penetration of ifosfamide and its active metabolite 4-OH-ifosfamide into cerebrospinal fluid of patients with CNS malignancies.
Kiewe P; Neumann M; Wagner T; Seyfert S; Albrecht H; Thiel E; Korfel A
Cancer Chemother Pharmacol; 2011 Jan; 67(1):27-33. PubMed ID: 20182727
[TBL] [Abstract][Full Text] [Related]
14. [Metabolism of enantiomers of the cytostatic ifosfamide].
Blaschke G; Widey W
Arzneimittelforschung; 1989 Feb; 39(2):223-6. PubMed ID: 2730691
[TBL] [Abstract][Full Text] [Related]
15. Effects of phenobarbital on stereoselective metabolism of ifosfamide in rats.
Lu H; Wang JJ; Chan KK; Young D
Drug Metab Dispos; 1998 May; 26(5):476-82. PubMed ID: 9571229
[TBL] [Abstract][Full Text] [Related]
16. Identification of biliary metabolites of ifosfamide using 31P magnetic resonance spectroscopy and mass spectrometry.
Payne GS; Dzik-Jurasz AS; Mancini L; Nutley B; Raynaud F; Leach MO
Cancer Chemother Pharmacol; 2005 Oct; 56(4):409-14. PubMed ID: 15877229
[TBL] [Abstract][Full Text] [Related]
17. Renal clearance of ifosfamide.
Springate J; Zamlauski-Tucker MJ; Lu H; Chan KK
Drug Metab Dispos; 1997 Sep; 25(9):1081-2. PubMed ID: 9311624
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450.
Chen CS; Jounaidi Y; Waxman DJ
Drug Metab Dispos; 2005 Sep; 33(9):1261-7. PubMed ID: 15919850
[TBL] [Abstract][Full Text] [Related]
19. Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers.
Ducharme MP; Bernstein ML; Granvil CP; Gehrcke B; Wainer IW
Cancer Chemother Pharmacol; 1997; 40(6):531-3. PubMed ID: 9332469
[TBL] [Abstract][Full Text] [Related]
20. Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites.
Woodland C; Ito S; Granvil CP; Wainer IW; Klein J; Koren G
Life Sci; 2000 Nov; 68(1):109-17. PubMed ID: 11132240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
